Oct. 25 at 12:57 PM
$ZPTA Prior to joining Merck, Mr. Golestani was responsible for establishing and managing strategic client relationships from business development through consulting services engagement delivery as a principal with Oracle (oracle.com).
Previously, Mr. Golestani served as chairman of the board for Sparta Systems (acquired by Honeywell); and on the Board of Directors for Ciox Health (merged with Datavant), Liaison Technologies (acquired by OpenText), Molecula Corp (acquired by Circuit), Seal Software (acquired by DocuSign), NPower (npower.org), ToposWare, Inc. (acquired by Polygon Labs), TruU, Inc. (truu.io), and UMUC/Ventures (umucventures.org). He has a degree in Management Science from Massachusetts Institute of Technology Sloan School of Management, and is a cofounder of Cross Road Technologies, Inc., in Cambridge, Massachusetts.